# Tag: GLP-1 drugs

- [RD Saúde Adjusted Profit Rises 23% as Digital Sales Surge](https://brazilstockguide.com/insights/rd-saude-adjusted-profit-rises-23-as-digital-sales-surge/) (2026-08-04): GLP-1 demand and market-share gains lift revenue 18%, while free cash flow turns positive and leverage falls to 0.8 times EBITDA.
- [Anvisa Approves EMS’s Ozivy, Brazil’s First Semaglutide Pen](https://brazilstockguide.com/insights/ems-ozivy-semaglutide-pen-anvisa-approval-brazil/) (2026-05-26): The first synthetic analogue of Ozempic approved in Brazil uses semaglutide and opens a new front in the multibillion-dollar GLP-1 drug market.
- [The drug that is drying up consumption](https://brazilstockguide.com/behind-the-lines/the-drug-that-is-drying-up-consumption/) (2026-04-15): Rising use of weight-loss pens is cutting alcohol, snacks and dining out — and creating a new spending pattern.